Unità Operativa Ematologia 1 - Università degli Studi di Bari
Welcome,         Profile    Billing    Logout  
 7 Trials 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liso, Vincenzo
NCT01064570: AIDA 2000 Guidelines

Recruiting
2
600
Europe
all-trans retinoic acid (ATRA)
Gruppo Italiano Malattie EMatologiche dell'Adulto
Acute Promyelocytic Leukemia
 
 
NCT01064557: "AIDA" Protocol (LAP 0493)

Recruiting
N/A
1068
Europe, RoW
all-trans retinoic acid (ATRA)
Gruppo Italiano Malattie EMatologiche dell'Adulto
Leukemia
12/20
12/20
Specchia, Giorgina
FISM_registry, NCT02808858: Italian Network MDS Registry

Recruiting
N/A
10000
Europe
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Myelodysplastic-Myeloproliferative Diseases
06/16
05/32
CML1012, NCT01752062: Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors

Recruiting
N/A
148
Europe
Gruppo Italiano Malattie EMatologiche dell'Adulto
Chronic Myeloid Leukemia, Pregnancy
12/22
12/22
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

Recruiting
N/A
400
Europe
Treatment for clinical practise
Fondazione Italiana Linfomi ONLUS
Classical Hodgkin Lymphoma
01/26
01/26
CARLUCCIO, Paola
ACROBAT, NCT04184505 / 2019-003997-25: Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS

Recruiting
3
274
Europe
Azacitidine, AZA, Standard Chemotherapy, STD CHT, Allogeneic stem cell transplantation, HSCT
Gruppo Italiano Malattie EMatologiche dell'Adulto, AIFA - Italian Medicines Agency, Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Franco Mandelli Onlus
High-risk MDS
03/24
03/24
GITMO-PHYLOS, NCT03270748: Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

Completed
2
78
Europe
GvHD prophylaxis
Gruppo Italiano Trapianto di Midollo Osseo
Myeloid Malignancies
11/22
11/22
NCT03751917: Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia

Recruiting
N/A
100
Europe
Arsenic Trioxide, ATRA+ATO
Gruppo Italiano Malattie EMatologiche dell'Adulto
Acute Promyelocytic Leukemia
12/24
12/24

Download Options